We are live on !
Find out more
Simplify Asset Management Portfolio holdings
AUM
$7.19B
Turnover
25.77%
1-Year Est. Return
6.88%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
–
AUM
$7.19B
AUM Growth
+$670M
(+10%)
Cap. Flow
+$436M
Cap. Flow % of AUM
Cap. Flow %
6.07%
Top 10 Holdings %
Top 10 Hldgs %
91.65%
Holding
163
New
20
Increased
70
Reduced
37
Closed
22
Avg Time Held
Equity + Options
1.2
years
Top 10 Avg Time Held
Equity + Options
1.5
years
Top 20 Avg Time Held
Equity + Options
1.2
years
Avg Time Held Equity only
1.2
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Simplify Government Money Market ETF
SBIL
|
+$311M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$93.2M |
| 3 |
UnitedHealth
UNH
|
+$14.6M |
| 4 |
Simplify China A Shares PLUS Income ETF
CAS
|
+$11.6M |
| 5 |
PureCycle Technologies
PCT
|
+$11.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$36.1M |
| 2 |
Simplify Short Term Treasury Futures Strategy ETF
TUA
|
+$14.9M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$8.67M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$8.42M |
| 5 |
Align Technology
ALGN
|
+$6.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.55% |
| 2 | Healthcare | 5.05% |
| 3 | Energy | 0.44% |
| 4 | Industrials | 0.38% |
| 5 | Technology | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Simplify Piper Sandler US Small-Cap PLUS Income ETF
LITL
$6.7M
| $3.15M | 0.04% |
91,464
| – | – |
2025 Q2
4 quarters
|
|
52
Intuitive Surgical
ISRG
$153B
| $2.98M | 0.04% |
7,492
-3,275
| -30% | -$1.43M |
2021 Q4
18 quarters
|
|
53
Simplify Ancorato Target 25 Distribution ETF
XXV
$48.9M
| $2.76M | 0.04% |
116,500
-8,500
| -7% | -$201K |
2025 Q4
2 quarters
|
|
54
Phathom Pharmaceuticals
PHAT
$567M
| $2.7M | 0.04% |
249,267
-13,119
| -5% | -$150K |
2023 Q1
13 quarters
|
|
55
Simplify US Equity PLUS Managed Futures Strategy ETF
CTAP
$165M
| $2.64M | 0.04% |
100,000
| – | – |
2025 Q4
2 quarters
|
|
56
Corcept Therapeutics
CORT
$12.1B
| $2.3M | 0.03% |
26,434
-11,329
| -30% | -$684K |
2026 Q1
1 quarter
|
|
57
CALL
Invesco QQQ Trust
QQQ
$485B
| $2.21M | 0.03% |
+3,000
| New | +$2.06M |
2026 Q2
0 quarters
|
|
58
Abeona Therapeutics
ABEO
$252M
| $2.13M | 0.03% |
345,416
-162,572
| -32% | -$893K |
2024 Q2
8 quarters
|
|
59
Pacira BioSciences
PCRX
$1.45B
| $2.11M | 0.03% |
83,083
+20,430
| +33% | +$483K |
2024 Q4
6 quarters
|
|
60
Cisco
CSCO
$420B
| $1.99M | 0.03% |
16,904
-2,955
| -15% | -$309K |
2025 Q3
3 quarters
|
|
61
Celldex Therapeutics
CLDX
$2.33B
| $1.98M | 0.03% |
53,134
-15,860
| -23% | -$512K |
2025 Q3
3 quarters
|
|
62
Walmart Inc
WMT
$942B
| $1.91M | 0.03% |
16,890
+2,673
| +19% | +$332K |
2025 Q3
3 quarters
|
|
63
Abbott
ABT
$180B
| $1.86M | 0.03% |
20,546
+5,040
| +33% | +$460K |
2021 Q4
18 quarters
|
|
64
Dynex Capital
DX
$2.62B
| $1.76M | 0.02% |
134,500
+52,921
| +65% | +$696K |
2025 Q4
2 quarters
|
|
65
Edwards Lifesciences
EW
$50.3B
| $1.69M | 0.02% |
18,668
+4,590
| +33% | +$385K |
2024 Q4
6 quarters
|
|
66
Kyverna Therapeutics
KYTX
$361M
| $1.63M | 0.02% |
182,603
+9,497
| +5% | +$84.3K |
2025 Q4
2 quarters
|
|
67
MFA Financial
MFA
$648M
| $1.63M | 0.02% |
167,746
-41,254
| -20% | -$400K |
2025 Q4
2 quarters
|
|
68
Compass Pathways
CMPS
$1.54B
| $1.62M | 0.02% |
114,281
-44,771
| -28% | -$454K |
2025 Q3
3 quarters
|
|
69
Annaly Capital Management
NLY
$13.4B
| $1.61M | 0.02% |
71,839
+22,436
| +45% | +$495K |
2023 Q3
11 quarters
|
|
70
Insmed
INSM
$20.8B
| $1.51M | 0.02% |
14,190
+3,407
| +32% | +$413K |
2024 Q4
6 quarters
|
|
71
IBM
IBM
$223B
| $1.41M | 0.02% |
5,014
+224
| +5% | +$56.4K |
2025 Q3
3 quarters
|
|
72
Palantir
PLTR
$467B
| $1.4M | 0.02% |
12,021
+317
| +3% | +$43.2K |
2025 Q3
3 quarters
|
|
73
LeonaBio Inc
LONA
$47.6M
| $1.37M | 0.02% |
149,279
| – | – |
2023 Q1
13 quarters
|
|
74
Dell
DELL
$290B
| $1.37M | 0.02% |
3,172
+99
| +3% | +$28.6K |
2025 Q3
3 quarters
|
|
75
Berkshire Hathaway Class B
BRK.B
$1.14T
| $1.33M | 0.02% |
2,662
+40
| +2% | +$19.2K |
2026 Q1
1 quarter
|
|
Similar funds
SAM
Simplify Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Simplify Asset Management held 163 positions worth $7.19B, up 10% from $6.52B the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Simplify Asset Management deployed $436M of net new capital in Q2 2026, opening 20 new positions and adding to 70 existing holdings. Its largest new stake was Simplify China A Shares PLUS Income ETF: 428,078 shares worth $12.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 95% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $36.1M trimmed.
- Simplify Asset Management's largest Q2 2026 buy was Simplify China A Shares PLUS Income ETF: 428,078 shares worth $12.4M.
- Simplify Asset Management added most to Simplify Government Money Market ETF in Q2 2026, an estimated $311M increase.
- Simplify Asset Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $36.1M.
- Simplify Asset Management fully exited Regeneron Pharmaceuticals in Q2 2026, selling an estimated $8.42M.
- Simplify Asset Management's ten largest holdings make up 92% of its $7.19B portfolio in Q2 2026.
- Simplify Asset Management opened 20 new positions and closed 22 in Q2 2026.
- Simplify Asset Management's portfolio value rose 10% quarter-over-quarter to $7.19B.
Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.